David A. Cooper

Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.

D. Cooper, J. Zaunders, G. Kaufmann, 1999, Sexually transmitted infections.

CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.

D. Cooper, A. Kelleher, M. Law, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Characterization of the phenotypic and lymphokine profile associated with strong CD8+ anti‐HIV‐1 suppressor activity (CASA)

J. Zaunders, G. Guillemin, A. Carr, 2002, Clinical and experimental immunology.

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.

D. Cooper, A. Kelleher, J. Zaunders, 1999, The Journal of infectious diseases.

The microRNA‐9/B‐lymphocyte‐induced maturation protein‐1/IL‐2 axis is differentially regulated in progressive HIV infection

J. Zaunders, Sudha Rao, Jasmine Li, 2013, European journal of immunology.

Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption

D. Cooper, M. Davenport, S. Kent, 2017, Journal of Virology.

The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.

D. Tscharke, S. Alcântara, J. Zaunders, 2016, Vaccine.

Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals.

G. Stewart, D. Cooper, A. Kelleher, 1999, AIDS research and human retroviruses.

ALLOGENEIC BONE MARROW TRANSPLANTATION IN TWO HIV-1 INFECTED PATIENTS SHOWS NO DETECTABLE HIV-1 RNA OR DNA, AND A PROFOUND REDUCTION IN HIV-1 ANTIBODIES

J. Zaunders, J. Post, M. Bailey, 2015 .

Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs.

D. Cooper, J. Zaunders, M. Imai, 2001, AIDS research and human retroviruses.

Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group.

D. Cooper, A. Kelleher, J. Zaunders, 1998, The Journal of infectious diseases.